ASCO GI Webinar: Update on NET and HCC
At the Virtual Scientific Symposium on Gastrointestinal Cancers held on the 20th of March 2021, Dr Roland Leung and Dr Thomas Yau presented updates from ESMO 2020 and ASCO GI 2021 with a focus on gastroenteropancreatic neuroendocrine tumours (GEP-NETs) and hepatocellular carcinoma (HCC), respectively.
Detecting metastases with PSMA-PET in prostate cancer
Conventional imaging with computed tomography (CT), magnetic resonance imaging (MRI) and bone scans, are the current standard of care for imaging prostate cancer. Accurate imaging primarily relies on nodal metastases size for detection.
Combination therapy with a novel agent, albuvirtide, in hospitalised AIDS patients
Delayed therapy start and antiretroviral therapy (ART) resistance are two common issues affecting up to 33% and 17% of patients infected with human immunodeficiency virus (HIV), respectively. These patients commonly present with higher viral loads, lower CD4 T-cell count, and complications such as infections requiring acute treatment. For those patients presenting with acquired immunodeficiency syndrome (AIDS) or those who have breakthrough HIV, and who present with opportunistic infections and comorbidities requiring hospitalisation, ART treatments are limited.
CANCERINFORMER
BREAKING
